Summit Therapeutics
SMMT
$1.05
Share price
-7.08%
Change (1 day)
-80.59%
Change (1 year)
Categories
Market capitalization of Summit Therapeutics (SMMT)
Market cap: $0.10 Billion
As of May 2022 Summit Therapeutics has a market cap of $0.10 Billion. This makes Summit Therapeutics the world's 5742th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Summit Therapeutics from 2015 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.11 B | -57.82% |
| 2021 | $0.26 B | -32.01% |
| 2020 | $0.38 B | 259.7% |
| 2019 | $0.10 B | 468.07% |
| 2018 | $0.01 B | -88.56% |
| 2017 | $0.16 B | 57.11% |
| 2016 | $0.10 B | -25.33% |
| 2015 | $0.14 B |
End of Day market cap according to different sources
On May 15th, 2022 the market cap of Summit Therapeutics was reported to be:
$0.11 Billion
$0.11 Billion
$0.09 Billion
$0.11 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $5.94 B | 5,673.47% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.06 B | -32.32% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $0.59 B | 474.12% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | $6.16 B | 5,884.09% | 🇺🇸 USA |